Evidence map›Paper›PMID 31243993›Full record

ArticleBiochemistry2019

Munc13 Is a Molecular Target of Bryostatin 1.

Francisco A Blanco, Agnes Czikora, Noemi Kedei, Youngki You, Gary A Mitchell, Satyabrata Pany, Anamitra Ghosh, Peter M Blumberg, Joydip Das

Open access · bronzeAbstract read
In one paragraph

Article in Biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. InhibitingBiomedicines · 2025
    Article
  3. Article
  4. Marine-derived Compounds: A Powerful Platform for the Treatment of Alzheimer's Disease.Central nervous system agents in medicinal chemistry · 2024
    Review
  5. Journal of neurology, neurosurgery, and psychiatry · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Francisco A BlancoDepartment of Pharmacological & Pharmaceutical Sciences, College of Pharmacy , University of Houston , Houston , Texas 77204 , United States.
Agnes CzikoraLaboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute , National Institutes of Health , Bethesda , Maryland 20892 , United States.
Noemi KedeiLaboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute , National Institutes of Health , Bethesda , Maryland 20892 , United States.
Youngki YouDepartment of Pharmacological & Pharmaceutical Sciences, College of Pharmacy , University of Houston , Houston , Texas 77204 , United States.
Gary A MitchellLaboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute , National Institutes of Health , Bethesda , Maryland 20892 , United States.
Satyabrata PanyDepartment of Pharmacological & Pharmaceutical Sciences, College of Pharmacy , University of Houston , Houston , Texas 77204 , United States.
Anamitra GhoshDepartment of Pharmacological & Pharmaceutical Sciences, College of Pharmacy , University of Houston , Houston , Texas 77204 , United States.ORCID 0000-0001-9740-2070
Peter M BlumbergLaboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute , National Institutes of Health , Bethesda , Maryland 20892 , United States.
Joydip DasDepartment of Pharmacological & Pharmaceutical Sciences, College of Pharmacy , University of Houston , Houston , Texas 77204 , United States.ORCID 0000-0003-1540-5804
University of Houston · USNational Institutes of Health · US

Funding

Molecular Mechanism of Action of Phorbol EsterZIABC005270 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BLUMBERG, PETER · 2009 to 2018
$18.4M
Role of Munc13-1 as a presynaptic effector of ethanol actionR01AA022414 · NIAAA · UNIVERSITY OF HOUSTON · PI DAS, JOYDIP · 2015 to 2019
$1.8M
Characterization of a novel presynaptic target for ethanol actionR21AA020572 · NIAAA · UNIVERSITY OF HOUSTON · PI DAS, JOYDIP, ROMAN, GREGG W · 2011 to 2012
$394k
Intramural NIH HHS ZIA BC005270NIAAA NIH HHS R01 AA022414NIAAA NIH HHS R21 AA020572
6 · The paper itself

Abstract

Bryostatin 1 is a natural macrolide shown to improve neuronal connections and enhance memory in mice. Its mechanism of action is largely attributed to the modulation of novel and conventional protein kinase Cs (PKCs) by binding to their regulatory C1 domains. Munc13-1 is a C1 domain-containing protein that shares common endogenous and exogenous activators with novel and conventional PKC subtypes. Given the essential role of Munc13-1 in the priming of synaptic vesicles and neuronal transmission overall, we explored the potential interaction between bryostatin 1 and Munc13-1. Our results indicate that in vitro bryostatin 1 binds to both the isolated C1 domain of Munc13-1 ( K

Indexed as

AnimalsBinding SitesBryostatinsCell LineCells, CulturedMiceModels, MolecularMolecular Docking SimulationNerve Tissue ProteinsNeuronsPhorbol EstersProtein Bindingbryostatin 1BryostatinsNerve Tissue ProteinsPhorbol EstersUnc13a protein, mouse

Identifiers

PMID31243993
PMCPMC6620733
OpenAlexW2949050342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.